2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol

C110H73Br5N16O2 — CID 161402793

IUPAC2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol
SMILESBrc1cc2ccccc2cc1Br.Cc1cc(-c2cccc(Br)n2)n[nH]1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Oc4ccc5c6ccccc6n(-c6ccccn6)c5c4)ccc3c3cc4ccccc4cc3n2n1.Oc1ccc2c3ccccc3n(-c3ccccn3)c2c1
InChIInChI=1S/C36H23N5O.2C19H12BrN3.C17H12N2O.C10H6Br2.C9H8BrN3/c1-22-18-33-36-28(29-19-23-8-2-3-9-24(23)20-32(29)41(33)39-22)15-16-35(38-36)42-25-13-14-27-26-10-4-5-11-30(26)40(31(27)21-25)34-12-6-7-17-37-34;2*1-11-8-17-19-14(6-7-18(20)21-19)15-9-12-4-2-3-5-13(12)10-16(15)23(17)22-11;20-12-8-9-14-13-5-1-2-6-15(13)19(16(14)11-12)17-7-3-4-10-18-17;11-9-5-7-3-1-2-4-8(7)6-10(9)12;1-6-5-8(13-12-6)7-3-2-4-9(10)11-7/h2-21H,1H3;2*2-10H,1H3;1-11,20H;1-6H;2-5H,1H3,(H,12,13)
InChIKeyVULKHTMGCXROJQ-UHFFFAOYSA-N
MW2050.42 g/mol
LogP30.09
Rot. Bonds5

About 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol

2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol (PubChem CID 161402793) has the molecular formula C110H73Br5N16O2 and a molecular weight of 2050.42 g/mol. Its IUPAC name is 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol.

Molecular Properties

Compound Name2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol
PubChem CID161402793
Molecular FormulaC110H73Br5N16O2
Molecular Weight2050.42 g/mol
Exact Mass2044.20
IUPAC Name2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol
SMILESBrc1cc2ccccc2cc1Br.Cc1cc(-c2cccc(Br)n2)n[nH]1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Oc4ccc5c6ccccc6n(-c6ccccn6)c5c4)ccc3c3cc4ccccc4cc3n2n1.Oc1ccc2c3ccccc3n(-c3ccccn3)c2c1
InChIInChI=1S/C36H23N5O.2C19H12BrN3.C17H12N2O.C10H6Br2.C9H8BrN3/c1-22-18-33-36-28(29-19-23-8-2-3-9-24(23)20-32(29)41(33)39-22)15-16-35(38-36)42-25-13-14-27-26-10-4-5-11-30(26)40(31(27)21-25)34-12-6-7-17-37-34;2*1-11-8-17-19-14(6-7-18(20)21-19)15-9-12-4-2-3-5-13(12)10-16(15)23(17)22-11;20-12-8-9-14-13-5-1-2-6-15(13)19(16(14)11-12)17-7-3-4-10-18-17;11-9-5-7-3-1-2-4-8(7)6-10(9)12;1-6-5-8(13-12-6)7-3-2-4-9(10)11-7/h2-21H,1H3;2*2-10H,1H3;1-11,20H;1-6H;2-5H,1H3,(H,12,13)
InChIKeyVULKHTMGCXROJQ-UHFFFAOYSA-N
XLogP30.09
TPSA197.24 Ų
H-Bond Donors2
H-Bond Acceptors17
Rotatable Bonds5
Heavy Atoms133
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002050.42
LogP ≤ 530.09
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol?
The IUPAC name of 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol (CID 161402793) is 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol.
What is the SMILES notation for 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol?
The canonical SMILES for 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol is Brc1cc2ccccc2cc1Br.Cc1cc(-c2cccc(Br)n2)n[nH]1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Br)ccc3c3cc4ccccc4cc3n2n1.Cc1cc2c3nc(Oc4ccc5c6ccccc6n(-c6ccccn6)c5c4)ccc3c3cc4ccccc4cc3n2n1.Oc1ccc2c3ccccc3n(-c3ccccn3)c2c1.
What is the InChIKey of 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol?
The InChIKey is VULKHTMGCXROJQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H23N5O.2C19H12BrN3.C17H12N2O.C10H6Br2.C9H8BrN3/c1-22-18-33-36-28(29-19-23-8-2-3-9-24(23)20-32(29)41(33)39-22)15-16-35(38-36)42-25-13-14-27-26-10-4-5-11-30(26)40(31(27)21-25)34-12-6-7-17-37-34;2*1-11-8-17-19-14(6-7-18(20)21-19)15-9-12-4-2-3-5-13(12)10-16(15)23(17)22-11;20-12-8-9-14-13-5-1-2-6-15(13)19(16(14)11-12)17-7-3-4-10-18-17;11-9-5-7-3-1-2-4-8(7)6-10(9)12;1-6-5-8(13-12-6)7-3-2-4-9(10)11-7/h2-21H,1H3;2*2-10H,1H3;1-11,20H;1-6H;2-5H,1H3,(H,12,13).
What are the key properties of 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol?
2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol has a molecular weight of 2050.42 g/mol, XLogP of 30.09, 5 rotatable bonds, 2 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-6-(5-methyl-1H-pyrazol-3-yl)pyridine;bis(9-bromo-4-methyl-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene);2,3-dibromonaphthalene;4-methyl-9-(9-pyridin-2-ylcarbazol-2-yl)oxy-2,3,8-triazapentacyclo[11.8.0.02,6.07,12.015,20]henicosa-1(21),3,5,7(12),8,10,13,15,17,19-decaene;9-pyridin-2-ylcarbazol-2-ol is sourced from PubChem (CID 161402793), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).